Past Medical History: RLL NSCLC T2N0M0 [**8-9**] RLL lobectomy plus LN dissection [**9-13**] readmission for hydropneumothorax [**9-19**] R chest exploration, debridement, closure of bronchus [**10-19**] Eloesser procedure, omental graft and bronchal closure [**11-17**] tracheostomy, thoracotomy, redo omental flap COPD h/o candica sepsis h/o MRSA tracheobronchitis c-section x3  Social History: 100PY h/o smoking  Family History: N/c  Physical Exam: VS 52kg  98.3 (99.1)  102/58  73  20  97%TM   97-99% 2LNC NAD, A&Ox3 trach size 6 fenestrated, capped RRR, B CTA R chest deep curving granulating cleen cavity, open bronchus exposed in depth Abd soft, NT/ND, BS + B LE WWP, no edema  Pertinent Results: [**2186-1-2**] 09:35AM BLOOD WBC-10.1 RBC-3.64* Hgb-11.8* Hct-35.6* MCV-98 MCH-32.5* MCHC-33.3 RDW-18.5* Plt Ct-419 [**2186-1-2**] 09:35AM BLOOD Plt Ct-419 [**2186-1-5**] 10:00AM BLOOD Glucose-155* UreaN-10 Na-137 K-4.2 Cl-92* HCO3-34* AnGap-15 [**2186-1-2**] 09:35AM BLOOD Lipase-33 [**2186-1-6**] 05:30AM BLOOD CK-MB-NotDone cTropnT-<0.01 [**2186-1-5**] 10:00AM BLOOD Calcium-9.1 Phos-5.4*  CXR [**2186-1-6**] IMPRESSION 1.
Based on culture data, the fluconazole was discontinued on [**12-12**].
Per Infectious disease service pt was started on vanco based on culture data from wound.
